Sign up Log-In

Home Page Strains Strain Detail

Back to Strains Library

Critical Mass

Overview:

Critical Mass is an earthy, yet citrusy indica. Composed of Skunk #1 and Afghani, Critical Mass is known for its massive, leafy branches. Since it is mostly leaves, the branches can begin to snap before they flower at six to eight weeks. However, beware of mold! Critical Mass is notorious for developing it. Since it is a strong indica, it is a good bedtime strain. It treats pain effectively due to the intense body buzz, as well as insomnia and anxiety. For anyone struggling with Post-Traumatic Stress Disorder symptoms, Critical Mass may be for you.

Strain Attributes:

Effects

Euphoric

Happy

Relaxed

Sleepy

Uplifted

Euphoric

Happy

Relaxed

Sleepy

Uplifted

Medical Uses

Depression

Insomnia

Muscle Spasms

Pain

Stress

Depression

Insomnia

Muscle Spasms

Pain

Stress

Negatives

Anxious

Dizzy

Dry Eyes

Dry Mouth

Paranoid

Anxious

Dizzy

Dry Eyes

Dry Mouth

Paranoid

Rate this Strain!

SPONSORS

FROM OUR BLOG

The Problem with Combining Cannabis Products and Prescription Medications

Cannabis as a drug can be classified as a depressant and stimulant. This is basically in terms of its reaction to the central nervous system. It also plays several roles in dealing with pain, inflammation, mediation of seizures, and dealing with different series of common ailments. This is why it is important that cannabis is seen as a drug and its interactions with other drugs are taken seriously.

Let People Die in Peaceful Bliss - Doctor Sues DEA to Let Him Give Psilocybin to Terminally Ill Patients

The Advanced Integrative Medical Science Institute (AIMS), a clinic co-founded by Dr. Sunil Aggarwal, has launched a lawsuit against the Drug Enforcement Administration (DEA). According to the lawsuit, Dr. Aggarwal was wrongfully refused clearance by the DEA to give psilocybin to patients who are near death. Dr. Aggarwal attempted to make advantage of Washington state's "Right-to-Try" Act, which permits the use of experimental drugs for end-of-life treatment.

Cannabis for Parkinson's Disease has a Breakthrough, but More Research is Needed

Next month, the Parkinson’s Foundation will hold a two-day meeting to bring 40 experts including clinicians, scientists, executives from the cannabis industry, and physicians who will discuss cannabis for Parkinson’s treatment.